-
1دورية أكاديمية
المؤلفون: Kondo, YoshinobuAff1, Aff2, Aff3, IDs13340024007176_cor1, Satoh, ShinobuAff2, Aff4, Terauchi, Yasuo
المصدر: Diabetology International. 15(3):474-482
-
2دورية أكاديمية
المؤلفون: Min Lei, Xiying Guo, Yue Yao, Ting Shu, Zhanhong Ren, Xiaosong Yang, Changhan Ouyang, Qingjie Chen, Chao Liu, Xiufen Liu
المصدر: Experimental Gerontology, Vol 182, Iss , Pp 112307- (2023)
مصطلحات موضوعية: Trelagliptin, Diabetes mellitus, Cognitive impairment, Learning and memory, Inflammation, Synaptic plasticity, Medicine, Biology (General), QH301-705.5
وصف الملف: electronic resource
-
3
المؤلفون: Zeng, S., Dou, W., Li, M., Zhou, Yang, 1989, Guo, J., Zhao, N., Huang, H., Zhou, Q., Hu, W., Ma, Y., Zhao, X., Xie, H.
المصدر: ChemMedChem. 15(16):1608-1617
مصطلحات موضوعية: biostability, DPP-IV, in silico testing, inhibitors, metabolism, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (1h pyrazol 4 yl)thieno[3, 2 d]pyrimidin 3(4h) yl]methyl] 4 fluorobenzonitrile, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 (pyridin 4 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 6 [3 (trifluoromethyl)phenyl]thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxo 7 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methoxypyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (2 methylpyridin 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (3, 5 dimethylisoxazol 4 yl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 (4 fluorophenyl) 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 6 [3 (methylsulfonyl)phenyl] 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 bromo 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 fluoro 4 oxothieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxo 6 (pyridin 3 yl)thieno[3, 2 [[2 (3 aminopiperidin 1 yl) 7 methyl 4 oxothieno[3, antidiabetic agent, cytochrome P450, dipeptidyl peptidase IV inhibitor, long acting drug, pyrimidine derivative, trelagliptin, unclassified drug, xanthine derivative, animal experiment, area under the curve, Article, computer model, controlled study, drug bioavailability, drug design, drug efficacy, drug half life, drug potency, drug transformation, glycemic control, IC50, in vitro study, in vivo study, infant, male, maximum plasma concentration, mean residence time, metabolic stability, nonhuman, priority journal, rat, time to maximum plasma concentration
وصف الملف: print
-
4دورية أكاديمية
المؤلفون: Zhang, Yatong, Li, Chao, Pei, Yifang, Zheng, Li, Sun, Xuelin, Zhao, Zinan, Wang, ShuanghuAff3
المصدر: Human Cell. 34(6):1717-1726
-
5دورية أكاديمية
المؤلفون: Zhou, Jia, Peng, Zhengliang, Wang, JianAff1
المصدر: Inflammation. 44(4):1507-1517
-
6دورية أكاديمية
المؤلفون: Chunnuan Wu, Huining Liu, Shuang Yu, Congcong Ren, Jie Zhang, Guopeng Wang, Bole Li, Yang Liu
المصدر: Biomedicine & Pharmacotherapy, Vol 153, Iss , Pp 113509- (2022)
مصطلحات موضوعية: Trelagliptin, Omarigliptin, Renal impairment simulation, DPP-4 occupancy, PBPK-DO model, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
-
7دورية أكاديمية
المؤلفون: Nishimura, Rimei, Osonoi, Takeshi, Koike, Yasuhiro, Miyata, KoujiAff3, Shimasaki, Yukio
المصدر: Advances in Therapy. 36(11):3096-3109
-
8كتاب إلكتروني
المؤلفون: LeRoy, Jenna M.Aff8, Stellpflug, Samuel J.Aff9
المساهمون: Brent, Jeffrey, editorAff1, Burkhart, Keith, editorAff2, Dargan, Paul, editorAff3, Hatten, Benjamin, editorAff4, Megarbane, Bruno, editorAff5, Palmer, Robert, editorAff6, White, Julian, editorAff7
المصدر: Critical Care Toxicology : Diagnosis and Management of the Critically Poisoned Patient. :1363-1386
-
9دورية أكاديمية
المؤلفون: Ishii, Hitoshi, Suzaki, Yuki, Miyata, Yuko, Matsui, ShingoAff2, IDs1330001906431_cor4
المصدر: Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 10(4):1369-1380
-
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.